Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 15, 2017
Teva Pharmaceutical announced the exclusive launch of generic Viread tablets 300 mg in the U.S.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
EMD Millipore, the Life Science division of Merck KGaA of Germany, announced today that it will host the third annual EMD Millipore Pharma Forum on June 12, 2012, at the company’s headquarters in Darmstadt, Germany. The event will bring together ...
read more
Three new chemists have joined Contract Research and Development Organization Arcinova’s Active Pharmaceutical Ingredient team.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Monday, December 21, 2020
Torrent is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing.
read more
Powder containment and aseptic transfer valve specialist ChargePoint Technology is expanding its U.S. presence, following a multi-million-pound investment from LDC.
read more
Trovagene has executed a supplier agreement with NerPharMa, to manufacture drug product for PCM-075.
read more
Friday, December 18, 2020
Ultragenyx Pharmaceutical and Mereo BioPharma Group announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
read more
Wednesday, April 16, 2014
Hovione announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost dry powder inhaler (DPI) to Hovione. This happened less than three years after the patent was filed and after just ...
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Monday, December 21, 2020
Vectura Group announced an expansion of its capabilities to handle and develop HPAPIs at its facility in Chippenham, U.K.
read more
Vectura Group announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K.
read more